Indication
Treatment of advanced levodopa-responsive Parkinson’s disease (PD) with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of Parkinson medicinal products have not given satisfactory results.
Medicine details
- Medicine name:
- foslevodopa-foscarbidopa (Produodopa)
- SMC ID:
- SMC2574
- Pharmaceutical company
- AbbVie Ltd
- BNF chapter
- Central nervous system
- Submission type
- Abbreviated
- Publication due date:
- TBC